[Systolic blood pressure targets]

Area of Science:

• Cardiology
• Hypertension Management

Background:

• The optimal blood pressure target for reducing cardiovascular events and mortality is not definitively known.
• Previous studies like ACCORD did not show benefits of intensive systolic blood pressure treatment in diabetic patients.
• Systolic blood pressure (SBP) management is critical for cardiovascular health.

Purpose of the Study:

• To evaluate the impact of intensive systolic blood pressure treatment on cardiovascular outcomes.
• To determine if a lower SBP target reduces cardiovascular events and mortality.
• To assess the risks associated with intensive hypertension treatment.

Main Methods:

• The Systolic Blood Pressure Intervention Trial (SPRINT) compared intensive treatment (SBP < 120 mm Hg) with standard treatment (SBP < 140 mm Hg).
• Focused on patients with hypertension and increased cardiovascular risk.
• Monitored cardiovascular events and mortality.

Main Results:

• Intensive hypertension treatment significantly reduced the incidence of cardiovascular diseases.
• A lower SBP target was associated with a reduced risk of death.
• However, intensive treatment led to a statistically significant increase in side effects like hypotension and renal impairment.

Conclusions:

• More intensive systolic blood pressure treatment can lower cardiovascular disease incidence and mortality.
• The benefits of intensive treatment must be weighed against the increased risk of adverse events such as hypotension and renal issues.
• Further research is needed to establish optimal SBP targets for diverse patient populations.